Tubular disorders in low birth weight neonates after prolonged antibiotic treatment

Vasileios I Giapros1, Foteini K Papadimitriou, Styliani K Andronikou

  • 1Neonatal Intensive Care Unit, Child Health Department, University of Ioannina, Ioannina, Greece. vgiapros@cc.uoi.gr

Neonatology
|March 9, 2007
PubMed

Insights

Combined antibiotic treatment with aminoglycosides (AGs) and vancomycin (VM) in extremely low birth weight (ELBW) infants can cause kidney problems. These renal tubular disturbances, including electrolyte wasting, resolved after stopping the drugs.

Area of Science:

  • Neonatal Medicine
  • Pharmacology
  • Nephrology

Background:

  • Aminoglycosides (AGs) and vancomycin (VM) are critical antibiotics for neonatal infections but carry nephrotoxicity risks.
  • Co-administration of AGs and VM is common in adult patients, increasing nephrotoxicity.
  • The impact of combined AG and VM therapy on renal function in extremely low birth weight (ELBW) infants (<1,000 g) remains underreported.

Observation:

  • This study investigated tubular dysfunction in five ELBW neonates receiving prolonged, repeated courses of combined AGs and VM.
  • Drug levels were consistently maintained within the therapeutic neonatal range throughout treatment.

Findings:

  • All studied neonates exhibited renal tubular wasting of potassium, phosphate, and calcium, leading to hypokalemia.
  • Hypophosphatemia was observed in three neonates, and transient elevations in serum creatinine occurred in four.
  • All documented renal disturbances resolved completely within 1-2 weeks after treatment cessation.

Implications:

  • Renal tubular disturbances from AG and VM treatment may be more prevalent in ELBW neonates than currently recognized.
  • Early identification of these subclinical renal effects is crucial for timely intervention.
  • Appropriate electrolyte supplementation can effectively manage and normalize serum electrolyte levels in affected infants.
Abstract

Related Concept Videos

Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...